Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-23FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for divalproex sodium from Aurobindo Pharma Limited.
-
FDA label_change · 2015-09-18FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC.
-
FDA approval · 2015-09-17FDA Approved: GABAPENTIN — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for gabapentin filed by Advagen Pharma Ltd. The approval updates the approved generic product as par…
-
FDA approval · 2015-09-17FDA Approved: GABAPENTIN — Supplemental Application (Granules Pharmaceuticals Inc)
The FDA approved a supplemental application for Gabapentin from Granules Pharmaceuticals Inc, authorizing a generic gabapentin product to be…
-
FDA approval · 2015-09-11FDA Approved: OXTELLAR XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
FDA approved a supplemental application for OXTELLAR XR (oxcarbazepine) from Supernus Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-11Clinical Trial Update: Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy [NA]
This update reports the completion of a clinical trial evaluating strategies to improve medication adherence and health-related quality of l…
-
FDA approval · 2015-09-10FDA Approved: GABAPENTIN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for gabapentin filed by Sun Pharmaceutical Industries, Inc. The approval reflects a supplemental cha…
-
FDA approval · 2015-09-10FDA Approved: APTIOM — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for APTIOM (eslicarbazepine acetate) from Sumitomo Pharma America, Inc., signaling an update to the …
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Pediatric Seizure Movement Bed Alarm
A completed pediatric trial assessed a movement-based bed alarm for seizure monitoring in children.
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy [Phase 3]
A Phase 3 trial evaluating internet-delivered Modified Atkins Diet in adults with intractable epilepsy has completed.
-
FDA label_change · 2015-08-28FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) submitted by Novartis, resulting in labeling changes.
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs [Phase 2]
Phase 2 pediatric trial evaluating pharmacokinetics, efficacy, and safety of perampanel oral suspension for reducing seizures in children on…
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Medication Adherence in Individuals With Epilepsy
Completed clinical trial update on medication adherence in individuals with epilepsy; results were posted in August 2015.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation [Phase 1]
Phase 1 trial evaluating dosage form proportionality of the opicapone to-be-marketed formulation; the study in epilepsy completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial Epilepsy [Phase 4]
A Phase 4 study compared levetiracetam with oxcarbazepine as monotherapy in patients with newly or recently diagnosed partial epilepsy, with…
-
FDA approval · 2015-08-14FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for KEPPRA (levetiracetam) from UCB, Inc., resulting in an approved change to the drug's labeling.
-
FDA approval · 2015-08-13FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Levetiracetam from Torrent Pharmaceuticals Limited, updating the approved labeling under an …
-
FDA approval · 2015-08-13FDA Approved: LEVETIRACETAM — Original Application (Fresenius Kabi USA, LLC)
The FDA approved Fresenius Kabi USA, LLC's generic levetiracetam, expanding access to an anticonvulsant used to treat various seizure disord…
-
FDA approval · 2015-08-10FDA Approved: LEVETIRACETAM — Supplemental Application (Cranbury Pharmaceuticals, LLC)
FDA approved a supplemental application for levetiracetam (generic) submitted by Cranbury Pharmaceuticals, LLC. The action reflects an updat…
-
FDA approval · 2015-08-10FDA Approved: LEVETIRACETAM — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for levetiracetam from Amneal Pharmaceuticals LLC, advancing a generic version of the antiseizur…
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Lexapro for Major Depression in Patients With Epilepsy [Phase 4]
A Phase 4 trial evaluating Lexapro (escitalopram) for major depressive disorder in patients with epilepsy was terminated, with results poste…
-
FDA approval · 2015-07-31FDA Approved: LEVETIRACETAM — Original Application (Prasco Laboratories)
FDA approved an original application for levetiracetam by Prasco Laboratories.
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy [Phase 1]
Phase 1 clinical trial update describing completion of autologous bone marrow stem cell transplantation in patients with temporal lobe epile…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Antiepileptic Drugs and Osteoporotic Prevention Trial [Phase 4]
Phase 4 trial update on antiepileptic drugs and prevention of osteoporosis-related fractures in people with epilepsy. Results were posted in…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia (E-37) [NA]
This clinical trial update reports results from a study evaluating the automatic magnet mode of VNS Therapy in epilepsy patients with ictal …